Related Experiment Video
Updated: Apr 27, 2026
07:46
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
5.2K
Microfluidic 3D models of cancer.
Kyung Eun Sung1, David J Beebe1
1Department of Biomedical Engineering, University of Wisconsin, Madison, WI, USA; Paul P. Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI, USA.
Advanced Drug Delivery Reviews
|July 15, 2014
Summary
Microfluidic 3D cancer models offer a more accurate way to study tumors and their microenvironment. These advanced models improve cancer research and drug discovery by overcoming limitations of traditional methods.
Area of Science:
- Oncology
- Biomedical Engineering
- Cancer Biology
Background:
- Cancer remains a significant health challenge despite medical advances.
- Tumor-microenvironment interactions drive cancer initiation, progression, and drug resistance.
- Traditional cancer models (animal, in vitro) have limitations in replicating human physiology.
Purpose of the Study:
- To review the progress of microfluidic 3D cancer models.
- To highlight the benefits of these advanced models.
- To discuss their applications in cancer research and drug development.
Main Methods:
- Review of current literature on microfluidic 3D cancer models.
- Analysis of model capabilities in recapitulating tumor complexity.
- Evaluation of applications in basic research and drug discovery.
Main Results:
- Microfluidic 3D cancer models better mimic human tumor structures and functions.
- These models enhance the study of complex tumor-microenvironment interactions.
- They show promise in identifying novel drug targets and therapeutic strategies.
Conclusions:
- Microfluidic 3D cancer models represent a significant advancement over traditional methods.
- Their application can accelerate progress in understanding cancer biology.
- These models are valuable tools for efficient drug screening and discovery.
